Single-use Balloon Dilatation Catheter (AG-5251-083018 AG-5251-085518 AG-5251-088018 AG-5251-083019 AG-5251-085519 AG-5251-088019 AG-5251-083021 AG-5251-085521 AG-5251-088021 AG-5251-083024 AG-5251-085524 AG-5251-088024 AG-5251-103018 AG-5251-105518 AG-5251-108018 AG-5251-103019 AG-5251-105519 AG-5251-108019 AG-5251-103021 AG-5251-105521 AG-5251-108021 AG-5251-103024 AG-5251-105524 AG-5251-108024 AG-5251-123018 AG-5251-125518 AG-5251-128018 AG-5251-123019 AG-5251-125519 AG-5251-128019
Hangzhou AGS MedTech Co., Ltd. · Decision date Jun 24, 2026
What did the FDA decide?
FDA records K253393 as a 510(k) premarket notification, with a decision dated Jun 24, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Jun 24, 2026
Regulatory record facts
- Identifier
- K253393
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Hangzhou AGS MedTech Co., Ltd.
- Product code
- FGE
- Decision code
- SESE
- Decision date
- Jun 24, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stents, Drains And Dilators For The Biliary Ducts.
- Applicant
- Hangzhou AGS MedTech Co., Ltd.
- Product code
- FGE
- FDA device class
- 2
FDA decision timeline
K253393 received
Application receipt date recorded by FDA.
K253393 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code FGE
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Drainage CatheterK254179 | Canyon Medical Inc. | 510(k) clearance | Sep 18, 2026 | FDA |
| Medtronic, Inc. | 510(k) clearance | Sep 17, 2026 | FDA | |
| Q3 Medical USA, LLC (C/O Q3 Medical Devices Ltd.) | 510(k) clearance | Jul 27, 2026 | FDA | |
Dilation Balloon CatheterK253832 | Mirco-Tech (Nanjing) Co., Ltd. | 510(k) clearance | Apr 24, 2026 | FDA |
| Medi-Globe GmbH | 510(k) clearance | Apr 16, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Hangzhou AGS MedTech Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Hangzhou
Sources and methodology
- Original FDA record: K253393
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


